Skip to content

Daniel Martins

7 papers in the library · 100 citations · publishing 2017-2024

Papers

Sort Most recent Most cited

Mechanistic Insights into the Neurotoxicity of 2,5-Dimethoxyphenethylamines (2C) and Corresponding N-(2-methoxybenzyl)phenethylamine (NBOMe) Drugs.

Journal of Xenobiotics June 5, 2024 Eva Gil-Martins, Fernando Cagide-Fagín, Daniel Martins et al. 2 citations

Substituted phenethylamines including 2C (2,5-dimethoxyphenethylamines) and NBOMe (N-(2-methoxybenzyl)phenethylamines) drugs are potent psychoactive substances with little to no knowledge available on their toxicity. In the present in vitro study, we explored the mechanisms underlying the neurotoxicity of six substituted phenethylamines: 2C-T-2, 2C-T-4, 2C-T-7 and their corresponding NBOMes....

DOI: 10.3390/jox14020044 (opens in new tab) Full text (opens in new tab) 2c drugs Nbome drugs New psychoactive substances Substituted phenethylamines +17

Bonding to Psychedelics: Synthesis of Molecularly Imprinted Polymers Targeting 4-Bromo-2,5-dimethoxyphenethylamine (2C-B)

Applied Sciences Switzerland February 1, 2024 Daniel Martins, Carlos Fernandes, Ricardo F. Mendes et al.

The increasing interest in utilizing psychedelics for therapeutic purposes demands the development of tools capable of efficiently monitoring and accurately identifying these substances, thereby supporting medical interventions. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) has gained significant popularity as one of the most widely used psychedelic compounds in non-medical settings. In this...

Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol

Psychological Medicine October 17, 2023 Cathy Davies, Matthijs Geert Bossong, Daniel Martins et al. 9 citations

ABSTRACT Background Hippocampal hyperperfusion has been observed in people at Clinical High Risk for Psychosis (CHR), is associated with adverse longitudinal outcomes and represents a potential treatment target for novel pharmacotherapies. Whether cannabidiol (CBD) has ameliorative effects on hippocampal blood flow (rCBF) in CHR patients remains unknown. Methods Using a double-blind,...

Unraveling the In Vitro Toxicity Profile of Psychedelic 2C Phenethylamines and Their N-Benzylphenethylamine (NBOMe) Analogues

Pharmaceuticals August 15, 2023 Daniel Martins, Eva Gil-Martins, Fernando Cagide et al. 13 citations

Mescaline derivative (2C phenethylamines) drugs have been modified by the introduction of a N-2-methoxybenzyl group to originate a new series of compounds with recognized and potent psychedelic effects, the NBOMe-drugs. Although they are prevalent in unregulated drug markets, their toxicity profile is still poorly understood, despite several reports highlighting cases of acute intoxication,...

DOI: 10.3390/ph16081158 (opens in new tab) 2c drugs Hepg2 cells Nbome drugs Sh-sy5y cells +14

Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012–2021

Drugs, Habits and Social Policy November 24, 2022 Ruben Q Vrolijk, Fiona Measham, Adrià Quesada et al.

Purpose The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of “stronger” tablets (more mg MDMA per mg of tablet), or if tablets have simply been getting larger and heavier (more mg of tablet in total). Design/methodology/approach A data set...

The detection and prevention of unintentional consumption of DOx and 25x‐NBOMe at Portugal's Boom Festival

Human Psychopharmacology: Clinical and Experimental May 1, 2017 Daniel Martins, Monica J Barratt, Cristiana Vale Pires et al. 76 citations

Abstract Objective This paper describes the misrepresentation of LSD at Portugal's Boom Festival 2014 and the prevention of unintentional consumption of DOx and 25x‐NBOMe among LSD consumers attending a drug‐checking service. Methods Two hundred forty‐five drug samples expected to contain LSD were submitted to the drug‐checking service for chemical analysis. One hundred ten post‐test...

DOI: 10.1002/hup.2608 (opens in new tab) Drug Test biology Consumption sociology Boom +4

Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.

Drug Testing and Analysis February 2017 Tibor M Brunt, Constanze Nagy, Alexander Bücheli et al.

Drug testing is a harm reduction strategy that has been adopted by certain countries in Europe. Drug users are able to hand in their drugs voluntarily for chemical analysis of composition and dose. Drug users will be alerted about dangerous test results by the drug testing systems directly and through warning campaigns. An international collaborative effort was launched to combine data of drug...